-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JV3HSQ9HKg5UWbvYOEQKd5XHqEnINHHUgdPQsguVtHM0fOzbMC3qqsS1NvuMiUHG heQvNXHZlBwN2s8TiG6NgA== 0000897069-08-001296.txt : 20080813 0000897069-08-001296.hdr.sgml : 20080813 20080813172641 ACCESSION NUMBER: 0000897069-08-001296 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080811 FILED AS OF DATE: 20080813 DATE AS OF CHANGE: 20080813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOFMEISTER THOMAS CENTRAL INDEX KEY: 0001307464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 081014461 BUSINESS ADDRESS: BUSINESS PHONE: 301-280-4555 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 form4_thomashofmeisterex.xml X0303 4 2008-08-11 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001307464 HOFMEISTER THOMAS TWO BETHESDA METRO CENTER, SUITE 1200 BETHESDA MD 20814 0 1 0 0 VP of Finance & CAO Common Stock 2008-08-11 4 S 0 1765 16.9405 D 23250 D The shares of common stock were sold to cover taxes incurred as a result of vesting of restricted shares. These shares were sold at a range of sale prices from $16.89 to $16.9701. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares and fully vested shares which total 13,235 shares of stock from an initial grant of 15,000 shares of restricted stock; (ii) unvested restricted shares and fully vested shares which total 8,065 shares of stock from an initial grant of 10,000 shares of restricted stock made on June 12, 2006; and (iii) unvested restricted shares and fully vested shares which total 1,950 shares of stock from an initial grant of 5,000 shares of restricted stock made on October 29, 2004. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Teri L. Champ, Attorney-in-Fact 2008-08-13 -----END PRIVACY-ENHANCED MESSAGE-----